FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers Post author:PacConAdmin Post published:July 29, 2025 Post category:Uncategorized FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers Source: FDA Press Releases Tags: aaps Read more articles Previous PostFDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients Next PostFDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks You Might Also Like Legislative Update — Week of May 20, 2024 May 20, 2024 GSK Nabs FDA Approval for First Drug for Treatment of Myelofibrosis September 18, 2023 Novartis Joins Fight Against IRA With Lawsuit Challenging Constitutionality September 5, 2023